01/01/19, Present, Syneos, Innovaderm, Galderma, Nimbus, AbbVie, Catawba, Lab Corp, KPL, Dermavant Allakos, Fortrea Freenom, Universal DX, Iqvia, Aslan, Takeda, Ventyx Anaptis Bio, Escient, Sun Pharma, Cara therapeutics, Arena Pfizer PPD, Arcutis, GSK, Opsidio, Phase II Moderate to Severe Psoriasis, Phase III Severe Psoriasis, Phase III Atopic Dermatitis, Phase II Acne, Phase III Prurigo nodularis, Phase II Moderate to Severe Pediatric Psoriasis, Phase II Rosacea, Phase III Alopecia Areata, Blood sample collection Cancer screening, Phase III Chronic Spontaneous Urticaria trials, Phase II Hidradenitis Suppurativa, Phase III Notalgia Paresthetica, Phase II Atopic Dermatitis, Phase III Alopecia, Phase II Palmoplantar Pustulosis, Phase III Acne, Phase III Vitiligo, Phase II Notalgia Paresthetica, Phase II Staph vaccine, Phase II Actinic keratosis, Phase III Eczema, Phase II Urticaria, Phase III Urticaria, Warts
Title: Sub-Investigator